CCT - Crypto Currency Tracker logo CCT - Crypto Currency Tracker logo
Bitcoin Magazine 2024-12-10 22:05:09

MicroStrategy (MSTR) Expected To Be Added To Nasdaq 100: Bloomberg

Follow Nikolaus On 𝕏 Here For Daily Posts Today, Bloomberg ETF analysts Eric Balchunas and James Seyffart announced that MicroStrategy (MSTR) is expected to enter into the Nasdaq 100 (QQQ) later this month on December 23. $MSTR is likely to be added to $QQQ on 12/23 (w/ announcement coming 12/13). Moderna likely to get boot (symbolic). Below is best guess of adds/drops via @JSeyff . Likely a 0.47% weight (40th biggest holding). There's $550b of ETFs tracking the index. S&P 500 add next yr prob. pic.twitter.com/rmTavtvWQL — Eric Balchunas (@EricBalchunas) December 10, 2024 “MicroStrategy will likely enter the Nasdaq 100 Index on Dec. 23, and we expect net buying of at least $2.1 billion in shares by ETFs to follow, equal to about 20% of daily volume,” Seyffart explained . “Joining the S&P 500 will be tougher because of a lack of profit, though an accounting-rule change surrounding Bitcoin valuations could make MicroStrategy eligible in 2025.” Net buying of $2.1 billion would be an added boost to MSTR, which has already outperformed most major stocks and also bitcoin this year — up 450% year-to-date at the time of writing. MSTR, powered by its relentless bitcoin acquisition strategy, has seen its stock skyrocket to a new all time high this year for the first time since March 10, 2000. MSTR has already acquired over 170,000 bitcoin since announcing its plans to raise $42 billion to purchase more BTC in late October. Balchunas stated that the official announcement of MSTR getting added to QQQ is expected to come this Friday, December 13. “Again this is our best estimate of what will go down,” Balchunas concluded . “We don't work at Nasdaq. FYI!”

阅读免责声明 : 此处提供的所有内容我们的网站,超链接网站,相关应用程序,论坛,博客,社交媒体帐户和其他平台(“网站”)仅供您提供一般信息,从第三方采购。 我们不对与我们的内容有任何形式的保证,包括但不限于准确性和更新性。 我们提供的内容中没有任何内容构成财务建议,法律建议或任何其他形式的建议,以满足您对任何目的的特定依赖。 任何使用或依赖我们的内容完全由您自行承担风险和自由裁量权。 在依赖它们之前,您应该进行自己的研究,审查,分析和验证我们的内容。 交易是一项高风险的活动,可能导致重大损失,因此请在做出任何决定之前咨询您的财务顾问。 我们网站上的任何内容均不构成招揽或要约